Susquehanna International Group LLP boosted its position in Cytosorbents Co. (NASDAQ:CTSO – Get Rating) by 379.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,943 shares of the medical research company’s stock after buying an additional 25,281 shares during […]